11 Matching Annotations
  1. Last 7 days
  2. www.sciencedirect.com www.sciencedirect.com
    Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection
    1
    1. scibot 19 Jul 2024
      AB_2563830

      DOI: 10.1016/j.isci.2024.110283

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004224015086
  3. May 2024
  4. www.sciencedirect.com www.sciencedirect.com
    SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
    1
    1. scibot 23 May 2024
      RRID:AB_2563830

      DOI: 10.1016/j.xcrm.2024.101583

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379124002751
  5. Jun 2022
  6. www.sciencedirect.com www.sciencedirect.com
    The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
    1
    1. scibot 15 Jun 2022
      RRID:AB_2563830

      DOI: 10.1016/j.immuni.2022.05.018

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761322002382
  7. Apr 2022
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
    1
    1. scibot 07 Apr 2022
      RRID:AB_2563830

      DOI: 10.1016/j.xcrm.2022.100600

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8960124/
  9. Mar 2022
  10. www.sciencedirect.com www.sciencedirect.com
    Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
    1
    1. scibot 06 Mar 2022
      RRID:AB_2563830

      DOI: 10.1016/j.xcrm.2022.100557

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379122000647
  11. Jan 2022
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Complement activation induces excessive T cell cytotoxicity in severe COVID-19
    1
    1. scibot 20 Jan 2022
      RRID:AB_2563830

      DOI: 10.1016/j.cell.2021.12.040

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8712270/
  13. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
    1
    1. scibot 05 Jan 2022
      RRID:AB_2563830

      DOI: 10.1016/j.chom.2021.12.010

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8683262/
  14. Nov 2021
  15. www.sciencedirect.com www.sciencedirect.com
    Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation
    1
    1. scibot 05 Nov 2021
      RRID:AB_2563830

      DOI: 10.1016/j.ccell.2021.10.008

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610821005596
  16. Jul 2021
  17. www.nature.com www.nature.com
    Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
    1
    1. scibot 21 Jul 2021
      RRID:AB_2563830

      DOI: 10.1038/s41591-021-01404-8

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41591-021-01404-8
  18. Mar 2021
  19. link.springer.com link.springer.com
    Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
    1
    1. scibot 06 Mar 2021
      RRID:AB_2563830

      DOI: 10.1007/s00262-021-02895-7

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1007/s00262-021-02895-7
  20. Oct 2020
  21. www.cell.com www.cell.com
    Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
    1
    1. scibot 31 Oct 2020
      RRID:AB_2563830

      DOI: 10.1016/j.cell.2020.08.017

      Resource: (BioLegend Cat# 309820, RRID:AB_2563830)

      Curator: @evieth

      SciCrunch record: RRID:AB_2563830

      What is this?
      RRID:AB_2563830 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell/abstract/S0092-8674(20)31008-4